Algernon Pharmaceuticals Announces Last Patient Treated in Phase 2 Study of IPF and Chronic Cough Read more
Stevanato Group and Owen Mumford Sign Exclusive Collaboration Agreement for the Innovative Aidaptus Auto-Injector Read more
Apnimed Announces $62.5 Million Series C Financing to Advance Development of Novel Pharmaceutical Treatments for Obstructive Sleep Apnea (OSA) and Related Sleep Disorders Read more
CYTENA and ExcellGene to Develop Automated Workflows for Biotherapeutics Cell Line Development Read more
Novavax Requests Expanded Authorization of Nuvaxovid COVID-19 Vaccine to Adolescents Aged 12 through 17 Years in Great Britain Read more
Novartis Kymriah receives EC approval as first CAR-T cell therapy for adults with relapsed or refractory follicular lymphoma Read more
Amphista Therapeutics Enters Strategic Collaboration with Merck for Discovery and Development of Targeted Protein Degradation Therapeutics Read more
Sapience Therapeutics Receives FDA Orphan Drug Designation for ST101 for the Treatment of Advanced Melanoma Read more
Agastiya Biotech receives FDA Orphan Drug Designation for AB001 for Pancreatic cancer and Acute Myeloid Leukemia (AML) Read more